NCT03434600

Brief Summary

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the bone and on the difference in wear of the plastic insert. Finally, the functional outcome after surgery is compared between the two arthroplasties. Hypothesis: H1: The Sigma UKA has an equal migration pattern compared to the Oxford UKA with a follow up of two years - that is, no significant difference in migration between 1-2 years follow-up. H2: The Oxford and Sigma UKA's have comparable polyethylene wear with a follow up of 5 years. H3: The Oxford and Sigma UKA's have comparable patient perceived outcome measures (PROM) and leg extension power (LEP) postoperative. H4: BMD of the proximal tibia does not influence migration of the tibial component

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 9, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 15, 2018

Completed
Last Updated

May 20, 2019

Status Verified

May 1, 2019

Enrollment Period

3.8 years

First QC Date

February 9, 2018

Last Update Submit

May 16, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Migration of prosthesis

    RSA

    2 years follow-up

Secondary Outcomes (2)

  • Bone mineral density

    2 years follow-up

  • Polyethylene wear

    5 years follow-up

Study Arms (2)

Oxford

ACTIVE COMPARATOR

Patients receiving an Oxford UKA, which is the standard treatment for patients with medial osteoarthritis of the knee at our department.

Other: Oxford UKA vs Sigma UKA

Sigma

EXPERIMENTAL

Patients receiving a Sigma UKA, which is the experimental treatment.

Other: Oxford UKA vs Sigma UKA

Interventions

OxfordSigma

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All eligable patients with medial osteoarthritis of the knee.

You may not qualify if:

  • \- Inflammatory arthritis.
  • Patients who are not able to participate in the fast-track surgery program.
  • Patients with a contralateral knee arthroplasty.
  • Patients who are unable to provide informed consent.
  • Disseminated malignant disease (cancer) and treatment with radiation or chemotherapy.
  • Serious systemic disease (e.g.. hemiparesis and severe parkinsonism)
  • On-going case involving work injury of the knee.
  • Female patients with a wish of becoming pregnant in the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Daan Koppens

    Hospital Unit Vest

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 9, 2018

First Posted

February 15, 2018

Study Start

January 1, 2014

Primary Completion

November 1, 2017

Last Updated

May 20, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share